Ignite Creation Date:
2024-10-25 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06554626
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
Sponsor:
Organization:
None